Taiwan health insurance authority cuts drug review time 99%+
BCT helped a Taiwan health authority turn precedent-heavy drug review into AI-assisted decision support.

Client
The client is the national health insurance authority of a developed East Asian economy. It runs a single‑payer scheme that covers virtually the entire population. One of its core duties is deciding which new pharmaceutical products enter the national reimbursement list. These decisions carry major public health, budgetary, and policy impact. Each one must be defensible, consistent, and traceable against decades of precedent.